A pilot randomized controlled study of the impact of HMB on the improvement of sarcopenia in liver transplantation

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT1091220268

Enrollment

Registered

2016-12-06

Start date

2017-01-11

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients undergoing liver transplantation

Interventions

Intervention type:DRUG Name of intervention:Nutritional intervention Dose form / Japanese Medical Device Nomenclature:POWDER Route of administration / Site of application:ORAL,ENTERAL Dose per adminis

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who are going to undergo liver transplantation in Kyoto University

Exclusion criteria

Exclusion criteria: no

Design outcomes

Primary

Measure	Time frame
muscle mass, quality, and muscle power	—

Secondary

Measure	Time frame
complication, length of hospital stay, and so on	—

Countries

Japan

Contacts

Public ContactKaido Toshimi

Kyoto University

kaido@kuhp.kyoto-u.ac.jp+81-75-751-4323

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026